Mon, January 28, 2019
Fri, January 25, 2019
Thu, January 24, 2019
Wed, January 23, 2019
Tue, January 22, 2019
Fri, January 18, 2019
Thu, January 17, 2019

David Amsellem Upgraded (TEVA) to Hold and Increased Target to $16 on, Jan 23rd, 2019

David Amsellem of Piper Sandler, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $15 to $16 on, Jan 23rd, 2019.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ami Fadia of "Leerink Swann" Upgraded from Sell to Hold on, Monday, October 1st, 2018


These are the ratings of the 3 analyists that currently disagree with David


  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019
  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $27 on, Monday, November 5th, 2018
  • Jami Rubin of "Goldman Sachs" Maintained at Strong Buy and Held Target at $30 on, Monday, October 1st, 2018